Shire to test its ADHD drug in 4 to 5-year olds in U.S.

WASHINGTON (Reuters) - Shire Plc SHP.L has agreed to a U.S. Food and Drug Administration request to study its stimulant Vyvanse in preschool children as concern rises over the diagnosis and treatment of attention deficit hyperactivity disorder, the drugmaker said on Thursday.
Source: Reuters: Health - Category: Consumer Health News Tags: healthNews Source Type: news